Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Interventional, Exploratory Clinical Study of Tumor-Specific Cytotoxic T-Cell Injection (cCTL:GL01) for the Treatment of Advanced Gastrointestinal Tumors

NCT07735065 is registered in ClinicalTrials.gov with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.

NCT NCT07735065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07735065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Interventional, Exploratory Clinical Study of Tumor-Specific Cytotoxic T-Cell Injection (cCTL:GL01) for the Treatment of Advanced Gastrointestinal Tumors
Lead sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 1, 2028
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastrointestinal cancer